Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Diabetologia
|
January 28, 2012
Complement C3: an emerging risk factor in cardiometabolic disease
E Hertle, M M J van Greevenbroek, C D A Stehouwer
Molecular Immunology
|
July 15, 2014
The complement system in human cardiometabolic disease
E Hertle, C D A Stehouwer, M M J van Greevenbroek
The Netherlands Journal of Medicine
|
June 1, 2013
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences
M M J van Greevenbroek, C G Schalkwijk, C D A Stehouwer
The Netherlands Journal of Medicine
|
April 28, 2010
Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia
M C G J Brouwers, C J H van der Kallen, N C Schaper, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 12, 2012
Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance
M M J van Greevenbroek, S Ghosh, C J H van der Kallen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 3, 2009
Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study
M C G J Brouwers, J M Dekker, M M J van Greevenbroek, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 27, 2007
Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus
M M J van Greevenbroek, V M M-J Vermeulen, E J M Feskens, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
January 22, 2013
Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia
M C G J Brouwers, R J Konrad, T M van Himbergen, et al.
European Journal of Clinical Investigation
|
April 29, 2009
Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study
M Jacobs, M M J van Greevenbroek, C J H van der Kallen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study
M Piazza, N M J Hanssen, F Persson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Diabetologia
|
January 28, 2012
Complement C3: an emerging risk factor in cardiometabolic disease
E Hertle, M M J van Greevenbroek, C D A Stehouwer
Molecular Immunology
|
July 15, 2014
The complement system in human cardiometabolic disease
E Hertle, C D A Stehouwer, M M J van Greevenbroek
The Netherlands Journal of Medicine
|
June 1, 2013
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences
M M J van Greevenbroek, C G Schalkwijk, C D A Stehouwer
The Netherlands Journal of Medicine
|
April 28, 2010
Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia
M C G J Brouwers, C J H van der Kallen, N C Schaper, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 12, 2012
Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance
M M J van Greevenbroek, S Ghosh, C J H van der Kallen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 3, 2009
Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study
M C G J Brouwers, J M Dekker, M M J van Greevenbroek, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 27, 2007
Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus
M M J van Greevenbroek, V M M-J Vermeulen, E J M Feskens, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
January 22, 2013
Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia
M C G J Brouwers, R J Konrad, T M van Himbergen, et al.
European Journal of Clinical Investigation
|
April 29, 2009
Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study
M Jacobs, M M J van Greevenbroek, C J H van der Kallen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study
M Piazza, N M J Hanssen, F Persson, et al.
Page
of 2